Tandem Diabetes Care launches Control-IQ+ automated insulin delivery technology in the US
ReutersMar 18, 2025 9:41 PM
March 18 (Reuters) - Tandem Diabetes Care Inc TNDM.O:
TANDEM DIABETES CARE LAUNCHES NEW CONTROL-IQ+ AUTOMATED INSULIN DELIVERY TECHNOLOGY IN THE UNITED STATES
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Netflix Q1 2025 Preview: Subscriber Momentum Meets Margin Scrutiny
TradingKey - Netflix enters its Q1 2025 earnings report on a wave of guarded optimism. Analysts expect Netflix to post strong year-over-year growth in Q1, with consensus revenue at 1.5billion (+11.7% YoY) and EPS at 5.67(+7.4%YoY).TradingKey
4 hours ago
[Reuters Breakingviews] Trump kicks all of Asia into the China tariff boat
HONG KONG, April 3 (Reuters Breakingviews) - Donald Trump’s second trade war is a battle of one against all. Reciprocal tariffs announced on Wednesday by the White House hit China with a hike of 34 percentage points, taking the fresh levies on exports from the People’s Republic up 5...Reuters
Thu, Apr 3
2 Big Takeaways From Morgan Stanley’s Outlook for 2025
TradingKey - Normally, many asset and wealth managers will release 2025 outlooks with their expert forecasts for the upcoming year. They provide a good barometer for investors to understand the various scenarios that could play out in financial markets.TradingKey
Thu, Jan 2
US Stock Market’s 2025 Outlook: Navigating the Shifting Landscape
TradingKey - Anyone who has invested in US stocks in 2024 will be happy. The US stock market has delivered an absolutely blockbuster performance so far this year, with the S&P 500 Index soaring 26.9% year-to-date (as of December 16), reaching record highs.TradingKey
Mon, Dec 30
